Objective-To obtain further information about the risks of childhood leukaemia after exposure to ionising radiation at low doses and low dose rates before or after birth or to the father's testes shortly before conception.
Introduction
Evidence for the magnitude of the risk of childhood leukaemia after childhood exposure to ionising radiation delivered at a high dose rate is substantial from studies of the Japanese survivors of the atomic bomb,' infants given radiotherapy for supposed thymus enlargement,2 and children irradiated for tinea capitis.3 Studies of the effects of diagnostic x rays in pregnancy also provide good quantitative evidence of the magnitude of the risk to the fetus after high dose rate exposures. 4' In contrast, there is still considerable uncertainty about the magnitude of the risk after exposures to low doses of ionising radiation delivered at low dose rates.
Reports of an increased incidence of childhood leukaemia in the vicinity of the two nuclear installations in Britain in which nuclear fuel is reprocessed67 have given rise to concern about the possible effects of radioactive pollution of the environment, concern which has been greatly exacerbated by knowledge of the pollution caused by the nuclear accident at Chernobyl. Estimates of the risks involved8 have suggested that the amounts of waste dispersed in western Europe would not produce any detectable effect, not even as a result ofthe accident at Chernobyl.9 These estimates, however, are based on the effects of high dose rate exposure, and they have not, hitherto, taken account of the possibility suggested by Gardner et al that irradiation ofthe testes may cause an increased risk of leukaemia in any offspring subsequently con- ceived within a few months.'0 It therefore seems important to test the validity of the estimates by direct observation of the effects of the waste. Such an opportunity is provided by examining the trends in the incidence of childhood leukaemia around the time when nuclear weapons were being tested intensively in the atmosphere, as the pollution which has given rise to concern is similar in character to that produced by weapons testing.
An early attempt to use trends in mortality from leukaemia in childhood and in the incidence of leukaemia in England and Wales was complicated by temporal changes in the efficacy of treatment and in the efficiency of cancer registration," and we can hope to obtain useful information only from data on incidence of leukaemia recorded by cancer registries that were already operating before 1962. We have, therefore, sought evidence from the cancer registries in Denmark, Finland, Iceland, Norway, and Sweden, which together cover a large enough population (about 20 million) to provide figures subject to proportionately small random error, which have long obtained practically complete registration, and which cover countries where radioactive fallout from weapons testing was relatively high. The possible effects of irradiation from fallout received (a) after birth, (b) in utero, or (c) to the father's testes were examined by fitting a further series of models in which the observed numbers of leukaemia registrations were assumed to depend on their associated populations and also on country, sex, age, and exposure category. Exposure category was derived from the data given in table I in several ways. Firstly, for radiation received after birth the data for age and calendar year of diagnosis were grouped into exposure categories ( fig 1) . This grouping was obtained by considering the classification of calendar years for the dose equivalent to the bone marrow of a 1 year old child, shown in table I, and assuming that red bone marrow exposure in a given calendar year could affect only children born before the year in question; that children aged under 1 year would not be affected; and that for older children the effect of exposure in any given year would be apparent in the calendar year after the year in which the exposure occurred and would last for seven years. This period was chosen with reference to studies of individuals exposed to high doses of radiation, such as patients with ankylosing spondylitis treated with x rays,'4 in whom the risk of radiation induced leukaemia seems greatest from one to seven years after exposure. For each age specific and calendar year specific group the data were allocated to the high exposure category if subjects were found to be affected by fallout received in one or more high exposure years according to the rules given above and to the medium exposure category if they were found to be affected by fallout from at least one medium exposure year but no high exposure years. Secondly, for radiation received by the fetus the relevant exposure at every age was assumed to be the estimated bone marrow It was decided a priori to carry out all analyses for subjects aged 0-14 combined and also for those aged 0-4 separately as the reported increases in childhood leukaemia in the vicinity of nuclear installations are concentrated in the younger age group. Table II shows the estimates of the relative risks obtained when the data were classified by country, sex, age, and calendar year of diagnosis and when ages 0-14 years were included in the analysis, and figure 2 shows the corresponding rates of leukaemia by calendar year of diagnosis. As expected, the incidence rate at ages under 15 years in girls was significantly lower than in boys (relative risk 0-83; p<0 001). There were also significant differences in the relative risks by age at diagnosis (p<O0001 for heterogeneity), and they showed the characteristic pattern associated with childhood leukaemia-that is, an increase in incidence to a peak at ages 2-3 and then a steady decrease until at ages 9-14 the rate was only about two thirds of that experienced in the first year of life. Relative risks showed little variation between the five Nordic countries (p=0 22 for heterogeneity). Data for the calendar years before 1958 were available for Denmark alone, and so the rates during this period show considerable random variation (fig 2) . During 1958-79 the rates remained roughly constant, although the highest values occurred during three consecutive years 1967-9, which correspond roughly to the years when any effect of fallout dose to the red bone marrow ofthe child would be at a maximum. After 1979 there is some suggestion that the rates may be increasing.
Methods

Results
When the analysis was repeated including only children aged under 5 years at diagnosis the relative risks by sex, age qt diagnosis, and country were similar to those obtained with data on children at ages 0-14. Figure 3 shows the corresponding rates of leukaemia by calendar year. As before, greater variability was apparent before 1958, when only Danish data were available, and there was again some increase after 1979. During 1958-79 the rate seemed to rise to a peak in about 1967 and then to fall. The years surrounding 1967 correspond to the period when any effect of fallout dose to the red bone marrow of the child would be at a maximum. When the data were classified according to year of birth rather than calendar year of diagnosis the relative risks-by sex, age at diagnosis, and country remained very similar to those given in table II. Figure 4 shows the corresponding rates by calendar year of birth for ages 0-14 and figure 5 for ages 0-4. Increased variability was again apparent before 1958, when only Danish data were available. For children born in subsequent years no overall trends were apparent. When ages 0-14 were considered high rates of leukaemia were observed for children born in 1965, 1971, 1977, and 1982 (fig 4) , and when ages 0-4 were considered high rates were observed for children born in 1964-6, 1971, 1974, 1977, and 1979 (fig 5) . The period does not quite correspond with the period when any effect of fallout dose to the red bone marrow of the fetus or to the father's testes in the year before birth would be at a maximum, especially when considered in conjunction with the low rate of leukaemia observed in 1963.
EXPOSURE CATEGORIES BASED ON IRRADIATION OF RED BONE MARROW AFTER BIRTH
When data for calendar year of diagnosis were grouped into exposure categories based on irradiation of the red bone marrow after birth and ages 0-14 were BMJ VOLUME 304 considered the relative risks in the five exposure categories were not significantly different (p=0-22 for heterogeneity). The relative risk in the high exposure category was similar to that in the low exposure categories and slightly higher than in the medium exposure categories (table III) . When compared directly with that in the two medium exposure categories combined, the relative risk in the high exposure category was 1F07 (95% confidence interval 1-00 to [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . When only children aged under 5 years at diagnosis were considered there was evidence of differences between the exposure categories (p value for heterogeneity 0-02). The rate of leukaemia was high in the high exposure category (relative risk 1-10) and also in the second low category (1 a 10) (table III) . When compared with the two medium exposure categories combined the relative risk in the high exposure category was 1-11 (I00 to 1b24).
EXPOSURE CATEGORIES BASED ON IRRADIATION OF RED BONE MARROW OF FETUS
Data for calendar year ofbirth grouped into exposure categories defined according to the bone marrow dose from weapons fallout received by the fetus showed no significant differences between exposure categories at ages 0-14 (p >0 50 for heterogeneity; table III). When the high exposure category was compared with the two medium exposure categories combined, the relative risk was 1-03 (0 95 to 1-l1).
When only those aged under 5 years at diagnosis were considered there were again no significant differences between exposure categories (p >0 50 for heterogeneity; table III), and when the high exposure category was compared with the two medium exposure categories combined the relative risk was again 1-03 (0-93 to 1 15).
IRRADIATION TO FATHER S TESTES
Allocating data by calendar year of birth to exposure categories according to the likely dose to the father's testes during the year before birth showed no significant differences for either ages 0-14 or the restricted age group 0-4 (p >0 50 for heterogeneity in both cases; table III). When the high exposure category was compared with the two medium exposure categories combined the relative risk was 1 02 (0 94 to 1 11) for ages 0-14 and 1-08 (096 to IF22) for ages 0-4.
Discussion
In this study, data from the Nordic countries have confirmed the slightly higher risk ofleukaemia for boys compared with girls, and showed the characteristic age distribution of childhood leukaemias, with a peak at ages 2-3 years. When the data were classified according to the year ofbirth of the child, there was little evidence for an increased risk of leukaemia among children born in those years when fallout doses were highest, and similarly negative results were found when the birth cohorts were grouped into exposure categories based on estimated radiation dose to the fetus or to the father's testes. When the data were classified according to calendar year of diagnosis there were no strong overall trends but the rates of leukaemia in the later years of the study seemed to be increasing, and thev were also high in the late 1960s, when any effect of fallout dose to the red bone marrow would be at a maximum (figs 2 and 3) . These suggestions were stronger at ages 0-4 and were confirmed when the data were grouped into exposure categories based on bone marrow dose to the child. There was evidence of heterogeneity between the exposure categories at ages 0-4, with increased risks in the low exposure category at the end of the study and also in the high exposure category, when any effect of fallout would be at a maximum.
Organ doses from weapons fallout have not been estimated explicitly for the Nordic countries, but information is available on the levels of strontium-90 and '37Cs in milk and the total diet and on body burdens of '37Cs and 90Sr levels in bone in both Britain and the Nordic countries. High quality data on the Japanese survivors of the atomic bomb are not available for the period two to five years after exposure, which is the period for which the relative risks of leukaemia were greatest in the study of patients irradiated for ankylosing spondylitis,'4 and so the committee also assumed that the relative risk in this period would be the same as that observed in the period five to 15 years after exposure. Our study provides evidence that risks based on the survivors of the atomic bomb do not grossly underestimate the risks from low dose rate exposures. The present data are compatible with risks similar to or less than those predicted by the BEIR V committee, although they are also compatible with somewhat higher risks. Risks about double those predicted by the committee were found in a study of the effect of local fallout near the Nevada test site. 6 Dose equivalents received during the first year after the Chemobyl accident were reviewed by the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR).'5 Doses in the second year after the accident are estimated to be about half those in the initial year and doses in the third year about a fifth of those in the initial year.'7 If the total dose from the Chernobyl accident is assumed to be [1] [2] [3] [4] [5] [6] [7] 
